Naxitamab (Mouse IgG1)
Naxitamab (Hu3F8) (Mouse IgG1) is a mouse-derived IgG1 monoclonal antibody targeting the diazoglycoside GD2 (hu3F8) . Naxitamab can be used in the research of neuroblastoma, osteosarcoma, and other GD2-positive cancers[1].
Product Specifications
CAS Number
[1879925-92-4]
UNSPSC
12352203
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
[Naxitamab(MouseIgG1)]
References & Citations
[1]Cheung NK, et, al. Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology. 2012 Jul 1;1 (4) :477-486.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6159796-01 0.1 mL
RABEPK (Rab9 Effector Protein with Kelch Motifs, 40kD Rab9 Effector Protein, p40, RAB9P40) (PE)
Ask
View Details 
MBS6159796-02 5x 0.1 mL
RABEPK (Rab9 Effector Protein with Kelch Motifs, 40kD Rab9 Effector Protein, p40, RAB9P40) (PE)
Ask
View Details 